High Tech Pharm Co. Ltd (106190) — Cash Flow-to-Debt Ratio
High Tech Pharm Co. Ltd (106190) has a Cash Flow-to-Debt Ratio of 0.52x as of September 2025, meaning its operating cash flow of ₩6.60 Billion could theoretically repay 1% of its total liabilities (₩12.57 Billion) in one year. See how much free cash does High Tech Pharm Co. Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
High Tech Pharm Co. Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for High Tech Pharm Co. Ltd across 11 annual periods. Also explore High Tech Pharm Co. Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for High Tech Pharm Co. Ltd (2014–2024)
Year-by-year debt coverage analysis for High Tech Pharm Co. Ltd. For market capitalisation and broader financial context, see High Tech Pharm Co. Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.72x | ₩14.69 Billion | ₩20.35 Billion | ▲ +596.5% |
| 2023 | 0.10x | ₩2.91 Billion | ₩28.06 Billion | ▲ +190.3% |
| 2022 | -0.11x | ₩-3.70 Billion | ₩32.26 Billion | ▼ -148.1% |
| 2021 | 0.24x | ₩6.93 Billion | ₩29.05 Billion | ▲ +203.3% |
| 2020 | -0.23x | ₩-7.69 Billion | ₩33.30 Billion | ▼ -408.1% |
| 2019 | 0.07x | ₩2.48 Billion | ₩33.14 Billion | ▼ -58.7% |
| 2018 | 0.18x | ₩5.38 Billion | ₩29.65 Billion | ▼ -43.8% |
| 2017 | 0.32x | ₩5.45 Billion | ₩16.90 Billion | ▲ +281.7% |
| 2016 | 0.08x | ₩1.45 Billion | ₩17.13 Billion | ▼ -90.5% |
| 2015 | 0.89x | ₩12.71 Billion | ₩14.23 Billion | ▲ +27.6% |
| 2014 | 0.70x | ₩10.17 Billion | ₩14.53 Billion | — |